Source: Annual Congress 2012 - Prognosis of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Alves, J. Cruz, C. Pacheco, B. Fernandes, J. Cunha (Braga, Portugal). Prognostic value of SUVmax in patients with lung cancer who underwent surgical treatment. Eur Respir J 2012; 40: Suppl. 56, 4179

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019 Prognostic parameters in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Prognostic factors and surgical resection of pulmonary metastases from colorectal cancer Source: International Congress 2019 – General thoracic surgery Year: 2019 Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006 The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Inspiratory capacity is a new preoperative risk predictor in the patients with lung cancer undergoing surgical resection Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002 The surgical treatment of patients with lung metastases Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004 Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Source: Eur Respir Rev 2013; 22: 565-576 Year: 2013 Long-term results of surgically treated non-small cell lung cancer patients depending on the protocol of preoperative N-staging Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 The whole-body plethysmographic parameters are predictive of postoperative complications in cancer patients undergoing lung resection surgery Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010 FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Prognostic factors in patients with lung cancer and brain metastases at presentation Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Preoperative evaluation for patients undergoing lung resection surgery Source: Eur Respir J 2004; 24: Suppl. 48, 324s Year: 2004 Analyses of prognostic factors in patients undergoing surgery for lung cancer. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 Surgical treatment for lung metastases in patients with colorectal cancer Source: Annual Congress 2011 - General thoracic surgery I Year: 2011